Elan and Boehringer Ingelheim announce agreement for antibody-based therapeutics
9 February 2011 | By Boehringer Ingelheim
Announcement covers global technical development and manufacturing for antibody-based therapeutics...
List view / Grid view
News
Hamilton extends monitoring technology to 96-Channel Pipetting Head
8 February 2011 | By Dahlgren Communications
Hamilton introduces the TADM 96 Multi-Channel Pipetting Head, with aspiration & dispense monitoring technology in every channel...
Molecular Profiles installs Xcelodose system to speed drug development
8 February 2011 | By The Scott Partnership
Molecular Profiles, continues expansion of its manufacturing capabilities with the recent purchase of the Xcelodose 120S system...
Premier Research adds Patient Recruitment Expert to Team
8 February 2011 | By Premier Research Group Limited
Premier Research Group Ltd, announces the appointment of Sue Robinson to the position of Director of Patient Recruitment...
Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
8 February 2011 | By Johnson & Johnson
Johnson & Johnson and Crucell N.V. provide further information regarding Johnson & Johnson's proposed acquisition of Crucell...
Easing the transition into profitable manufacture
8 February 2011 | By Kapler Communications
New white paper from Malvern examines benefits of real-time analysis for process development...
AstraZeneca halts phase III trial of ZIBOTENTAN in non-metastatic castrate resistant prostate cancer
7 February 2011 | By AstraZeneca
AstraZeneca today announced that the phase III ENTHUSE Study 15...
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214 as a switch monotherapy treatment for major depressive disorder
7 February 2011 | By AstraZeneca
This study is in addition to the companies’ Phase III RENAISSANCE programme for TC-5214...
US FDA assigns new PDUFA date for BRILINTA (ticagrelor tablets)
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
NextPharma Technologies appoint new Quality Director at its Braine-l’Alleud site in Belgium
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
Aesica announces European appointments
3 February 2011 | By Aesica Pharmaceuticals
Following the recent announcement that it has signed contracts ahead of acquiring three manufacturing sites from UCB, Aesica Pharmaceuticals has appointed a team...
Andrew Packman to lead PwC’s UK pharmaceutical and life sciences business
3 February 2011 | By PwC
PwC has announced the appointment of Andrew Packman as head of the firm’s UK pharmaceutical and life sciences business...
Sigma Life Science & Cofactor Genomics develop rat genome database
2 February 2011 | By kdm communications limited
Plans include the generation and analyzing of sequence data, and to provide the samples and to host a new, free public database...
Exco InTouch introduces unique ‘Free SMS’ and ‘Free Data Download’ features
1 February 2011 | By The Scott Partnership
New measures will help drive down sponsor costs within clinical trials...
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
1 February 2011 | By Valeant Pharmaceuticals International Inc.
Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss...
